Copertina

Evaluating associations of migraine‐related vertigo

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Nazia Karsan, Nicolas Vandenbussche, Robyn Jenia‐Wilcha, Pubudu Amarasena, Pannathat Soontrapa, Karthik Nagaraj, Carlo Lastarria Perez, Peter J. Goadsby
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Headache: The Journal of Head and Face Pain
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The cortical spreading depression/migraine aura hypothesis – Finally some definitive evidence
di: Andrew C. Charles, et al.
Pubblicazione: (2025)

Flexible modeling of headache frequency fluctuations in migraine with hidden Markov models
di: Gina M. Dumkrieger, et al.
Pubblicazione: (2024)

Integrating gepants into clinical practice for the acute treatment of migraine
di: Richard B. Lipton, et al.
Pubblicazione: (2026)

Calcitonin gene‐related peptide‐targeting therapies are a first‐line option for the prevention of migraine: An American Headache Society position statement update
di: Andrew C. Charles, et al.
Pubblicazione: (2024)

Intracranial hypertension with papilledema associated with long‐term use of over‐the‐counter retinol day cream
di: Matthieu Batens, et al.
Pubblicazione: (2025)

Evaluating dual calcitonin gene‐related peptide antagonists for chronic migraine prevention
di: Kara S. Graves, et al.
Pubblicazione: (2026)

Depression and anxiety are not associated with migraine outcomes in children and adolescents
di: Amy A. Gelfand
Pubblicazione: (2024)

Causal associations between genetically predicted placental weight and migraine
di: Chung‐Chih Liao, et al.
Pubblicazione: (2025)

Time to reconsider the association between migraine and white matter hyperintensities?
di: Anders Hougaard
Pubblicazione: (2025)

Anxiety and depressive symptoms and migraine‐related outcomes in children and adolescents
di: Bilal Ahmed Rizvi, et al.
Pubblicazione: (2024)

No association between migraine and HLA alleles in a cohort of 13,210 individuals with migraine from the Danish Blood Donor Study
di: Inga Zalia Tummoszeit, et al.
Pubblicazione: (2024)

A history of abuse is associated with more severe migraine‐ and pain‐related disability: Results from the American Registry for Migraine Research
di: Meesha Trivedi, et al.
Pubblicazione: (2024)

The association between posttraumatic stress disorder and migraine: A systematic review
di: Lucie Nitsche, et al.
Pubblicazione: (2026)

Waning light, waxing pain: The lunar cycle's association with migraine headache occurrence
di: Alexander Yoo, et al.
Pubblicazione: (2025)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
di: Graham A. McLeod, et al.
Pubblicazione: (2025)

Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment
di: Andrea M. Kuczynski, et al.
Pubblicazione: (2025)

Evaluation of the effectiveness and safety of anti‐CGRP monoclonal antibodies in patients with migraine and autoimmune diseases: IMMUNO ‐ CGRP study
di: María Clara García‐Castillo, et al.
Pubblicazione: (2026)

Plain Language Summary Publication: Hyperactivity of the medial thalamus in patients with photophobia‐associated migraine
di: Yukihisa Suzuki, et al.
Pubblicazione: (2024)

Headache‐related disability as a function of migraine aura: A daily diary study
di: Delora E. Denney, et al.
Pubblicazione: (2024)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
di: Rikki Mangrum, et al.
Pubblicazione: (2024)

The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
di: Yunus Emre Meydanal, et al.
Pubblicazione: (2025)

Patient reported outcomes and the real‐world use of calcitonin gene–related peptide medications in migraine
di: Samuel K. Peasah, et al.
Pubblicazione: (2024)

Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐blind, placebo‐controlled trial
di: Muneto Tatsumoto, et al.
Pubblicazione: (2024)

Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine
di: Anna de Dios, et al.
Pubblicazione: (2024)

Patient satisfaction with calcitonin gene‐related peptide monoclonal antibodies in migraine: A multicenter prospective cohort study
di: Alba López‐Bravo, et al.
Pubblicazione: (2025)

Afterimage duration differs for migraine with or without aura
di: Florian Rimmele, et al.
Pubblicazione: (2025)

Mechanisms for mindfulness in migraine: Does catastrophizing matter?
di: Rebecca Erwin Wells, et al.
Pubblicazione: (2024)

Useful considerations for treating migraine in patients with autism
di: Sinifunanya E. Nwaobi
Pubblicazione: (2026)

Lifestyle triggers of migraine: Sleep restriction and caffeine lower the threshold for migraine‐like responses in rats in a sex‐specific manner
di: Gabriel Camargo de Oliveira, et al.
Pubblicazione: (2026)

Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
di: Shuu‐Jiun Wang, et al.
Pubblicazione: (2024)

Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
di: Chia‐Chun Chiang, et al.
Pubblicazione: (2024)

Differences in circulating alpha‐calcitonin gene–related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross‐sectional study
di: Marta Pascual‐Mato, et al.
Pubblicazione: (2024)

The effect of vestibular rehabilitation in the management of vestibular migraine in adults: A systematic review and meta‐analysis
di: Jad El Ahdab, et al.
Pubblicazione: (2025)

Efficacy of galcanezumab in proline‐rich transmembrane protein 2 ( PRRT2 ) ‐associated familial hemiplegic migraine: A case series
di: Costanza Sottani, et al.
Pubblicazione: (2024)

Counting the cost: How migraine shapes lives and economies
di: Risako Shirane, et al.
Pubblicazione: (2025)

Cardiovascular risk and triptan usage among patients with migraine
di: Ido Peles, et al.
Pubblicazione: (2025)

Cognitive and emotional mechanisms underlying migraine quality of life
di: Shiri Shinan‐Altman, et al.
Pubblicazione: (2026)

Assessing blood pressure changes and hypertension‐related outcomes in patients with migraine treated with erenumab: A systematic review and meta‐analysis
di: Luana Miyahira Makita, et al.
Pubblicazione: (2025)

Treatment of abdominal migraine in an 8‐year‐old child with calcitonin gene‐related peptide receptor antagonist: A case report
di: Yunzhu Tang, et al.
Pubblicazione: (2025)

Letter to the Editor regarding “Persistence, effectiveness, and tolerability of anti‐calcitonin gene‐related peptide monoclonal antibodies in patients with chronic migraine”
di: Joaquín Borrás‐Blasco, et al.
Pubblicazione: (2025)